MIRA
Price
$0.62
Change
-$0.06 (-8.82%)
Updated
Oct 22 closing price
Capitalization
26.22M
21 days until earnings call
Intraday BUY SELL Signals
SNY
Price
$41.96
Change
+$0.99 (+2.42%)
Updated
Oct 22 closing price
Capitalization
100.54B
8 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MIRA vs SNY

MIRA vs SNY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MIRA vs. SNY commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIRA is a Hold and SNY is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for MIRA with price predictions
Oct 22, 2026

MIRA in +6.18% Uptrend, growing for three consecutive days on October 21, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MIRA advanced for three days, in 103 of 122 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MIRA as a result. In 53 of 57 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for MIRA turned negative on October 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 27 similar instances when the indicator turned negative. In 25 of the 27 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

MIRA moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MIRA crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

MIRA broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MIRA entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.213) is normal, around the industry mean (-3.019). P/E Ratio (-0.511) is within average values for comparable stocks, (21.251). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.738). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. MIRA's P/S Ratio (0.000) is slightly lower than the industry average of (4.033).

The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. MIRA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MIRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock worse than average.

A.I.Advisor
a Summary for SNY with price predictions
Oct 22, 2026

SNY's RSI Oscillator ascending out of oversold territory

The RSI Indicator for SNY moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In 19 of the 27 cases the stock moved higher. This puts the odds of a move higher at 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on SNY as a result. In 61 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.

The Moving Average Convergence Divergence (MACD) for SNY just turned positive on October 15, 2026. Looking at past instances where SNY's MACD turned positive, the stock continued to rise in 23 of 48 cases over the following month. The odds of a continued upward trend are 48%.

Following a +2.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNY advanced for three days, in 156 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.

SNY broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SNY entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. SNY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.453) is normal, around the industry mean (-3.019). P/E Ratio (25.508) is within average values for comparable stocks, (21.251). SNY's Projected Growth (PEG Ratio) (27.976) is very high in comparison to the industry average of (5.738). SNY's Dividend Yield (0.189) is considerably higher than the industry average of (0.041). P/S Ratio (1.829) is also within normal values, averaging (4.033).

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock worse than average.

FUNDAMENTALS RATINGS
SNY: Fundamental Ratings
SNY
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
81
PRICE GROWTH RATING
1..100
69
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MIRASNY
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
49%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
62%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
48%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
53%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
47%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 7 days ago
51%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 10 days ago
52%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
57%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
52%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (MIRA: $0.68 vs. SNY: $40.97)
Brand notoriety: MIRA and SNY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: MIRA: 13% vs. SNY: 104%
Market capitalization -- MIRA: $26.22M vs. SNY: $100.54B
MIRA [@Pharmaceuticals: Major] is valued at $26.22M. SNY’s [@Pharmaceuticals: Major] market capitalization is $100.54B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $4.8K to $1.13T. The average market capitalization across the [@Pharmaceuticals: Major] industry is $206.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIRA’s FA Score shows that 1 FA rating(s) are green while SNY’s FA Score has 1 green FA rating(s).

  • MIRA’s FA Score: 1 green, 4 red.
  • SNY’s FA Score: 1 green, 4 red.
According to our system of comparison, MIRA is a better buy in the long-term than SNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIRA’s TA Score shows that 2 TA indicator(s) are bullish while SNY’s TA Score has 4 bullish TA indicator(s).

  • MIRA’s TA Score: 2 bullish, 7 bearish.
  • SNY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SNY is a better buy in the short-term than MIRA.

Price Growth

MIRA (@Pharmaceuticals: Major) experienced а -0.04% price change this week, while SNY (@Pharmaceuticals: Major) price change was +3.02% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.73%. For the same industry, the average monthly price growth was -4.97%, and the average quarterly price growth was +5.45%.

Reported Earning Dates

MIRA is expected to report earnings on Nov 12, 2026.

SNY is expected to report earnings on Oct 30, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+0.73% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
MIRA
Daily Signal:
Gain/Loss:
SNY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

MIRA and

Correlation & Price change

A.I.dvisor tells us that MIRA and AMRN have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIRA and AMRN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRA
1D Price
Change %
MIRA100%
-8.48%
AMRN - MIRA
20%
Poorly correlated
+0.78%
GRFS - MIRA
17%
Poorly correlated
-0.67%
SNY - MIRA
15%
Poorly correlated
+2.42%
BIIB - MIRA
11%
Poorly correlated
+5.34%
AMGN - MIRA
10%
Poorly correlated
+2.04%
More

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with PFE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
+2.42%
PFE - SNY
47%
Loosely correlated
+1.91%
JNJ - SNY
36%
Loosely correlated
+3.81%
MRK - SNY
35%
Loosely correlated
-1.76%
AMGN - SNY
35%
Loosely correlated
+2.04%
GILD - SNY
34%
Loosely correlated
+2.36%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JRVR4.010.14
+3.62%
James River Group Holdings Ltd
ACGL102.692.41
+2.40%
Arch Capital Group Ltd
PETZ1.300.03
+2.36%
TDH Holdings
BBDC8.340.09
+1.09%
Barings BDC
CAAP24.44-0.99
-3.89%
Corporacion America Airports SA